The Morning Brief A Spoonful of Death
Oct 16, 2025
A tragic investigation reveals how contaminated cough syrups have led to the deaths of children in India. Grieving parents share heartbreaking accounts of their losses. Experts uncover the toxic substance diethylene glycol in these medicines and the regulatory neglect that allowed it to happen. The discussion highlights systemic flaws in drug safety, revealing the dangerous mix of outdated regulations and poor enforcement. Finally, the conversation turns to what reforms are needed to protect future generations from similar tragedies.
AI Snips
Chapters
Books
Transcript
Episode notes
Investigation Links Deaths To One Syrup
- Investigator Pramod Verma traced multiple child renal failures to the same prescribed cough syrup from one doctor and sought testing from Tamil Nadu.
- Lab results implicated the Kanshikuram maker and prompted local action against the company.
Manufacturer's Negligence And Regulatory Action
- Sreeshan Pharma repeatedly used industrial-grade solvents instead of pharma-grade propylene glycol and showed numerous GMP violations.
- Inspectors shut the plant, froze stocks and moved to cancel its licence amid culpable homicide charges.
Weak Punishments After Major Fatalities
- Multiple past incidents show DEG contamination in syrups killed children across India and abroad, involving several Indian firms.
- Many companies faced weak or reversible punishments, revealing regulatory fragility.
